Publications by authors named "Michael Haddock"

Objectives: Spatially fractionated radiation therapy (SFRT) intentionally delivers a heterogeneous dose distribution characterized by alternating regions of high and low doses throughout a tumor. This modality may enhance response to subsequent whole tumor radiation in bulky and radioresistant lesions that are historically less responsive to conventional radiation doses alone. The current study presents a single institution experience with modern era SFRT using predominantly a volumetric modulated arc therapy (VMAT) lattice technique.

View Article and Find Full Text PDF

Background: Anal squamous cell carcinoma (ASCC) is a rare cancer with increased occurrence of multiple cancers before and after the ASCC diagnosis. However, there is limited data on this aspect. This multi-institutional analysis aimed to define the occurrence of malignancies before and after ASCC, time trends, impact on survival, and identify prognostic factors.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness and safety of intraoperative radiation therapy (IORT) for treating recurrent cervical and endometrial cancer, along with identifying predictors of postoperative complications and mortality over three years.
  • A total of 80 patients were analyzed, revealing a 3-year survival rate of 48.6%, with complications occurring in 20.1% of cases and one patient dying within 30 days post-surgery.
  • Key risk factors linked to higher complications and mortality included poor performance status (ECOG PS 2-3), prior chemotherapy/immunotherapy, and the presence of pelvic sidewall involvement.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to create and assess EMVision, a system utilizing electromagnetic tracking technology to enhance the placement of brachytherapy applicators, focusing on procedure quality and efficiency.
  • EMVision integrates CT imaging and EMT reference frames for precise needle placement, using an automated system that displays real-time 3D visuals and adjusts for anatomy shifts during the procedure.
  • Results showed EMVision achieved high accuracy in needle placement, both in phantom tests and human cadaver evaluations, suggesting its potential to streamline brachytherapy procedures and improve training outcomes.
View Article and Find Full Text PDF

Purpose: To evaluate the safety and efficacy of pencil beam scanning (PBS) proton radiation therapy (RT) in trimodality therapy for esophageal cancer.

Methods And Materials: This prospective pilot study was planned to accrue 30 patients with locally advanced esophageal or gastroesophageal junction carcinoma medically suitable for chemoradiation therapy (CRT) followed by esophagectomy. PBS proton RT consisted of 25 fractions, 50 Gy to tumor + 1 cm and 45 Gy to a 3.

View Article and Find Full Text PDF
Article Synopsis
  • The NRG/RTOG 0436 study investigated whether adding cetuximab to chemoradiation for non-operative esophageal cancer would improve patient-reported outcomes (PROs), focusing on the FACT-Esophageal cancer subscale (ECS).
  • The study was stopped early due to failing to meet overall survival (OS) targets; among 344 enrolled patients, those receiving CRT plus cetuximab showed less improvement in ECS compared to those receiving standard CRT alone (37% vs. 53%).
  • Overall, the results indicated that adding cetuximab did not enhance PROs related to symptoms, swallowing, or eating, and there was no significant link between clinical complete
View Article and Find Full Text PDF

Purpose: Myxofibrosarcoma (MFS) is a subtype of soft tissue sarcoma with a highly infiltrative growth pattern that leads to a higher risk of inadvertent positive surgical margins and local relapse. Poorly defined tumor margins also pose a challenge for radiation therapy (RT) planning, in terms of treatment volumes and administration of pre- versus postoperative RT. This study aims to evaluate local control and patterns of recurrence in patients with MFS treated with neoadjuvant RT followed by definitive surgical excision.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the outcomes of spatially fractionated radiation therapy (SFRT) in 53 patients with bone and soft tissue sarcomas, emphasizing its effectiveness in treating resistant and bulky tumors from December 2019 to June 2022.
  • Most patients (87%) received SFRT for symptom relief, particularly using volumetric modulated arc therapy lattice, and a majority also underwent consolidative external beam radiation therapy (EBRT) shortly after SFRT.
  • The findings indicate a 53% one-year survival rate and an 82% local control rate, with a majority of patients experiencing symptom improvement and manageable toxicity, highlighting the promise of SFRT in sarcoma treatment.
View Article and Find Full Text PDF

. An algorithm was developed for automated positioning of lattice points within volumetric modulated arc lattice radiation therapy (VMAT LRT) planning. These points are strategically placed within the gross tumor volume (GTV) to receive high doses, adhering to specific separation rules from adjacent organs at risk (OARs).

View Article and Find Full Text PDF

Purpose: Total neoadjuvant therapy (TNT) is a newly established standard treatment for rectal adenocarcinoma. Current methods to communicate magnitudes of regression during TNT are subjective and imprecise. Magnetic resonance tumor regression grade (MR-TRG) is an existing, but rarely used, regression grading system.

View Article and Find Full Text PDF

Purpose: To provide clinical guidance for centers wishing to implement photon spatially fractionated radiation therapy (SFRT) treatments using either a brass grid or volumetric modulated arc therapy (VMAT) lattice approach.

Methods: We describe in detail processes which have been developed over the course of a 3-year period during which our institution treated over 240 SFRT cases. The importance of patient selection, along with aspects of simulation, treatment planning, quality assurance, and treatment delivery are discussed.

View Article and Find Full Text PDF

No standard treatment paradigm exists for previously irradiated locally recurrent rectal cancer (PILRRC). Carbon-ion radiotherapy (CIRT) may improve oncologic outcomes and reduce toxicity compared with combined modality therapy (CMT). Eighty-five patients treated at Institution A with CIRT alone (70.

View Article and Find Full Text PDF

Purpose/objectives: Proton beam therapy (PBT) may provide a dosimetric advantage in sparing soft tissue and bone for selected patients with extremity soft sarcoma (eSTS). We compared PBT with photons plans generated using intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT).

Materials/methods: Seventeen patients previously treated with pencil beam scanning PBT were included in this study.

View Article and Find Full Text PDF

Importance: For many types of epithelial malignant neoplasms that are treated with definitive radiotherapy (RT), treatment prolongation and interruptions have an adverse effect on outcomes.

Objective: To analyze the association between RT duration and outcomes in patients with esophageal cancer who were treated with definitive chemoradiotherapy (CRT).

Design, Setting, And Participants: This study was an unplanned, post hoc secondary analysis of 3 prospective, multi-institutional phase 3 randomized clinical trials (Radiation Therapy Oncology Group [RTOG] 8501, RTOG 9405, and RTOG 0436) of the National Cancer Institute-sponsored NRG Oncology (formerly the National Surgical Adjuvant Breast and Bowel Project, RTOG, and Gynecologic Oncology Group).

View Article and Find Full Text PDF

Surgical treatment of pelvic sarcoma involving the bone is the standard of care but is associated with several sequelae and reduced functional quality of life (QOL). Treatment with photon and proton radiotherapy is associated with relapse. Carbon ion radiotherapy (CIRT) may reduce both relapse rates and treatment sequelae.

View Article and Find Full Text PDF

Purpose/objective: Postoperative toxicity for esophageal cancer impacts patient quality of life and potentially overall survival (OS). We studied whether patient and toxicity parameters post-chemoradiation therapy predict for post-surgical cardiopulmonary total toxicity burden (CPTTB) and whether CPTTB was associated with short and long-term outcomes.

Materials/methods: Patients had biopsy-proven esophageal cancer treated with neoadjuvant chemoradiation and esophagectomy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effects of two types of radiation therapy—proton beam therapy (PT) and intensity-modulated radiation therapy (IMRT)—on patient-reported symptoms in endometrial cancer patients receiving adjuvant pelvic radiation.
  • A total of 67 patients participated, with 22 receiving PT and 45 receiving IMRT, and they reported their gastrointestinal and other symptoms using a specific questionnaire at various times after treatment.
  • Results indicated that PT was associated with less gastrointestinal issues, such as diarrhea, and fewer patients reported severe GI toxicity compared to those who received IMRT, suggesting PT may be a better option for minimizing side effects.
View Article and Find Full Text PDF

Background And Purpose: Chemotherapy followed by margin-negative resection (R0) is the treatment of choice for patients with localized pancreatic ductal adenocarcinoma (PDAC). Neoadjuvant multiagent chemotherapy (MAC) or MAC then radiotherapy (RT) may optimize surgical candidacy. The purpose of this study was to compare pathologic outcomes of MAC followed by conventionally fractionated radiotherapy (CRT) versus stereotactic body radiotherapy (SBRT) for patients with resected PDAC.

View Article and Find Full Text PDF

Background: Neoadjuvant therapy (NAT) is used in borderline resectable/locally advanced (BR/LA) pancreatic ductal adenocarcinoma (PDAC). Anatomic imaging (CT/MRI) poorly predicts response, and biochemical (CA 19-9) markers are not useful (nonsecretors/nonelevated) in many patients. Pathologic response highly predicts survival post-NAT, but is only known postoperatively.

View Article and Find Full Text PDF

Background: Intraoperative frozen-section analysis provides real-time margin resection status that can guide intraoperative decisions made by the surgeon and radiation oncologist. For patients with locally recurrent rectal cancer undergoing surgery and intraoperative radiation therapy, intraoperative re-resection of positive margins to achieve negative margins is common practice.

Objective: This study aimed to assess whether re-resection of positive margins found on intraoperative frozen-section analysis improves oncologic outcomes.

View Article and Find Full Text PDF

Purpose: Our purpose was to dosimetrically compare volumetric modulated arc therapy (VMAT) lattice radiation therapy (LRT), brass, and proton grid therapy planning techniques and suggest potential clinical applications for each.

Methods And Materials: Four plans delivering 20 Gy in 1 fraction were created for each of 22 patients. Brass and proton grid plans used a single static field and the same beam angle.

View Article and Find Full Text PDF

Background: This North Central Cancer Treatment Group (NCCTG) N064A (Alliance) phase II trial evaluated upfront chemoradiotherapy incorporating the EGFR inhibitor panitumumab, followed by gemcitabine and panitumumab for unresectable, non-metastatic pancreatic cancer.

Methods: The treatment consisted of fluoropyrimidine and panitumumab given concurrently with radiotherapy followed by gemcitabine and panitumumab for 3 cycles followed by maintenance panitumumab. The primary endpoint was the 12-month overall survival (OS) rate and secondary endpoints included confirmed response rate (RR), OS, progression-free survival (PFS), and adverse events.

View Article and Find Full Text PDF
Article Synopsis
  • Trastuzumab is a monoclonal antibody targeting HER2, and the NRG Oncology/RTOG-1010 trial aimed to determine its effectiveness in improving disease-free survival for patients with untreated HER2-overexpressing oesophageal adenocarcinoma when combined with standard treatments.
  • The trial was a phase 3, open-label study, recruiting 203 eligible adult patients from various institutions in the USA who had newly diagnosed oesophageal adenocarcinoma, stratified by their adenopathy status and randomly assigned to receive chemoradiotherapy with or without trastuzumab.
  • The primary goal of the study was to measure disease-free survival, defined as the time from randomization to death or recurrence of cancer, and the
View Article and Find Full Text PDF

Importance: Maximal resection is the preferred management for sacral chordomas but can be associated with unacceptable morbidity. Outcomes with radiotherapy are poor. Carbon ion radiotherapy (CIRT) is being explored as an alternative when surgery is not preferred.

View Article and Find Full Text PDF